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Equine infectious anemia (EIA) is caused by a persistent lentivirus
infection. Infected horses are lifelong reservoirs for vector medi-
ated or iatrogenic transmission of EIA virus (EIAV). No vaccine is
currently available or likely to become so. Therefore control of
new cases depends upon the time honored strategy of serological
identiﬁcation of carriers and their disposition by quarantine and
or slaughter. In the United States EIA prevalence has declined
from 4% in 1972 when the control program began to its current
prevalence of approximately 0.001%. The agar gel immunodiffu-
sion (AGID) test has been the regulatory test since EIAV control
program began 43 years ago. This 4,000 fold reduction in preva-
lence underscores the effectiveness of the AGID test but it has a
couple of drawbacks: it requires 48 hours to read and is not as
sensitive as newer serological tests. Alert clinicians, regulators
and horse owners seek to implement and facilitate better man-
agement of outbreaks, pre purchase evaluations and import/
export requirements. To address the need for a faster and more
sensitive assay we carried out this study to compare a USDA-
licensed AGID test kit with a USDA-licensed modiﬁed indirect
ELISA (MI-ELISA) kit. The serum sample from an EIAV carrier
horse was serially diluted and used to determine the analytical
sensitivity of each assay: the MI-ELISA was 4-fold more sensitive.
A Center for Veterinary Biologics proﬁciency panel (validated by
AGID test) of 20 samples was tested: there was 100% concordance
between the two assays. Analytical time point samples from 6
experimentally infected horses were collect over a period 4
months (n¼100): analytical sensitivity of experimentally infected
horses was comparable for the two assays. The two assays were
used to test known weak positive samples collected from nine
carrier horses: the AGID test detected only two but the MI-ELISA
detected all nine (Table). Due to the speed (45 minutes) and
signiﬁcantly greater sensitivity of the MI-ELISA reﬂected in the
results of this study, screening of routine samples with it andSamples MI-ELISA AGID
test
Mean Optical
density
(450 nm) and
result (+/-)
Visual
reading
QC lot EIA 0.128 - + -
P070507003 0.174 + + -
P110201-007 0.186 + + -
Reference W+ 0.222 + + -
M+ lot EIA 0.235 + + -
S #1 0.25 + + -
S #2 0.3 + + -
Princette Moon 0.673 + + W+
Todd 0.943 + + W+
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0.05 - - NA
AGID Positive Control +
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-
NA: not availableconﬁrmation of positives by the regulatory assay, AGID test,
would serve the needs of the equine industry for better and more
rapid risk management.
Comparison between the modiﬁed indirect enzyme-linked
immunosorbent assay (MI-ELISA) and agar gel immunodiffusion
(AGID) test in the sensitivity against the sera from weak EIA
positive carriers
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Equine infectious anaemia (EIA), equine viral arteritis (EVA) and
contagious equine metritis (CEM) are three major endemic equine
infectious diseases in France, although only a few cases have been
detected over the last ten years in the country. In view of the
serious economic impact of these diseases, three surveillance
systems have been implemented to monitor them. Each system is
dedicated to one disease and comprises various active and passive
surveillance components. The surveillance systems are imple-
mented separately even if they are based on similar components.
This lack of synergy may prevent optimal surveillance. Our
objective was to assess these surveillance systems and to compare
the results of the assessments in order to propose improvements,
including future synergies. We used the semi-quantitative OASIS
method1, already used to assess animal diseases and food safety
surveillance networks in different countries. We have identiﬁed
mutual strengths, including laboratories’ efﬁcacy, surveillance
tools and data collection. Contrarily, the current absence of central
institutional organizations, the poor data management and data
analysis were the main weaknesses of all systems (Figure 1).
Furthermore, the comparative assessment has highlighted manyFigure 1. Assessment of ten functional sections of the French EIA, EVA and
CEM surveillance systems using the OASIS method (the level of satisfaction
for each section is displayed as a percentage score).
